6/17/2020:

Instructions and new procedures for access to the Genomics facility are being shared through the brc-genomics-l mailing list and they will begin accepting samples for most services today.  Other facilities have also been communicating with users via their mailing lists.

 

 


 

6/12/2020:

All BRC facilities are now approved to resume services.  Detailed changes to procedures and timelines for the availability of services will be shared with facility users as soon as possible through mailing lists directed to those users.

 

The safety of our staff and the researchers who depend on our services is paramount. We look forward to serving our research community as we move to a new (and evolving) normal during this phased process. Throughout it all, we kindly ask for your continued patience and understanding.

 


 

6/11/2020:

The BRC Imaging and BRC Flow Cytometry Facility plans have been approved.  Users of those facilities should have already received guidance on how to access the equipment and services of those facilities.  

 

Re-opening plans for all BRC Genomics and BRC Proteomics & Metabolomics facility are currently under review by the Office of the Vice Provost for Research (OVPR). We are unable to share specific timelines or details for access to equipment and services in those facilities this time. Researchers can expect that some services may be limited, and that services and equipment access will not all become available at the same time.

 

The safety of our staff and the researchers who depend on our services is paramount. We look forward to serving our research community as we move to a new (and evolving) normal during this phased process. Throughout it all, we kindly ask for your continued patience and understanding.

 


 

6/4/2020:

Re-opening plans for all BRC Facilities are currently under review by the Office of the Vice Provost for Research (OVPR) and we have been coordinating with departments and building committees in all of the locations where we operate.

 

As we have not had any plans approved yet, we are unable to share specific timelines or details for access to our equipment and services at this time. Researchers can expect that some services may be limited, services and equipment access will not all become available at the same time.

 

Detailed information about timelines for specific services, as well as updated access, scheduling and sample submission procedures will be share as soon as possible after we receive confirmation that we are approved to resume operations per our reopening plans.

 

 

The safety of our staff and the researchers who depend on our services is paramount. We look forward to serving our research community as we move to a new (and evolving) normal during this phased process. Throughout it all, we kindly ask for your patience and understanding as we adapt to these difficult circumstances.

 


 

5/27/2020:

The Biotechnology Resource Center core facilities at the Cornell Institute of Biotechnology provide essential support for researchers. Now that Cornell is beginning a phased restart of research activities, our facilities are finalizing plans to resume operations and gain necessary approvals.

 

A complete shutdown and phased reopening of our operations has presented us with some unique challengesFor instance, some of our facilities offer user-operated instrumentation in close-quarters and certain other operations receive hundreds of samples per day under normal circumstances. To operate safely in this environment is an unprecedented challenge and requires that we modify our laboratory procedures and the ways instruments are accessed.

 

It is too early to say exactly which services will resume, when they will resume, and what limitations our users and customers can expect. We anticipate that some services will resume immediately upon receiving approval for our reopening plans, which could be as early as Monday, June 1. Others may not be ready for some days. Turnaround time is likely to be impacted for many services while facilities that house user-operated instrumentation will likely be operating with new scheduling constraints to meet social distancing requirements. In all cases, procedures for sample submission and lab access will be modified from pre-pandemic times and will be communicated here and via e-mail.

 

This is a rapidly changing situation. We will post updates here regularly and respond to questions submitted via e-mail or through our website contact form.

 

The safety of our staff and the researchers who depend on our services is paramount. We look forward to serving our research community as we move to a new normal during this phased process. Throughout it all, we kindly ask for your patience and understanding as we adapt to these difficult circumstances.

 

Information about Cornell's COVID-19 response including a link to the research reactivation planning document can be found here: https://www.cornell.edu/coronavirus/

 


 

3/15/2020

Cornell University has implemented a number of measures to protect the health, safety and well-being of our community in response to the COVID-19 pandemic.  The Cornell Institute of Biotechnology and associated BRC core facilities are moving to suspend operations as part of a University-wide move to cease all non-essential research activities beyond those activities essential to ensure a return to full operation in the future. All laboratory activitity beyond those essential activities will be suspended by Wednesday March 18, 2020.

  

All of our services and facilties will be impacted.  The specific impacts will vary by facility and service and will include no physical sample submission, increased turn-around time for samples already submitted, no access to in-person, user-operated instrumentation, delays in the advancement of large projects, and a reliance of phone and online and e-mail communication for consultations in lieu of face to face meetings. More specific information will be shared on a per-service basis or with specific facility users whose work is impacted.

 

For up-to-date information on Cornell University’s status and response to the COVID-19 pandemic, please see the University’s COVID-19 Resources and updates web site.